Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 4332 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Amgen and Abgenix begin phase III colon combo trial

The clinical trial, called PACCE, is a randomized, multi-center, open-label study, with endpoints of progression-free survival, overall survival and response rate. Enrollment of approximately 1,000 patients is already

Glenmark and Teijin form respiratory collaboration

The two companies have entered into a collaboration agreement for Glenmark’s PDE4 inhibitor GRC 3886, which is currently in development for chronic obstructive pulmonary disorder (COPD) and asthma.

APP gets approval for copycat anti-inflammatory

Dexamethasone sodium phosphate injection, a synthetic adrenocortical steroid anti-inflammatory drug, is used by intravenous or intramuscular injection when oral therapy is not feasible and indicated for endocrine, rheumatic